Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
Int J Radiat Oncol Biol Phys. 2024 Aug 1;119(5):1557-1568. doi: 10.1016/j.ijrobp.2024.02.016. Epub 2024 Feb 17.
The objective of this study was to develop a linear accelerator (LINAC)-based adaptive radiation therapy (ART) workflow for the head and neck that is informed by automated image tracking to identify major anatomic changes warranting adaptation. In this study, we report our initial clinical experience with the program and an investigation into potential trigger signals for ART.
Offline ART was systematically performed on patients receiving radiation therapy for head and neck cancer on C-arm LINACs. Adaptations were performed at a single time point during treatment with resimulation approximately 3 weeks into treatment. Throughout treatment, all patients were tracked using an automated image tracking system called the Automated Watchdog for Adaptive Radiotherapy Environment (AWARE). AWARE measures volumetric changes in gross tumor volumes (GTVs) and selected normal tissues via cone beam computed tomography scans and deformable registration. The benefit of ART was determined by comparing adaptive plan dosimetry and normal tissue complication probabilities against the initial plans recalculated on resimulation computed tomography scans. Dosimetric differences were then correlated with AWARE-measured volume changes to identify patient-specific triggers for ART. Candidate trigger variables were evaluated using receiver operator characteristic analysis.
In total, 46 patients received ART in this study. Among these patients, we observed a significant decrease in dose to the submandibular glands (mean ± standard deviation: -219.2 ± 291.2 cGy, P < 10), parotids (-68.2 ± 197.7 cGy, P = .001), and oral cavity (-238.7 ± 206.7 cGy, P < 10) with the adaptive plan. Normal tissue complication probabilities for xerostomia computed from mean parotid doses also decreased significantly with the adaptive plans (P = .008). We also observed systematic intratreatment volume reductions (ΔV) for GTVs and normal tissues. Candidate triggers were identified that predicted significant improvement with ART, including parotid ΔV = 7%, neck ΔV = 2%, and nodal GTV ΔV = 29%.
Systematic offline head and neck ART was successfully deployed on conventional LINACs and reduced doses to critical salivary structures and the oral cavity. Automated cone beam computed tomography tracking provided information regarding anatomic changes that may aid patient-specific triggering for ART.
本研究旨在开发一种基于线性加速器(LINAC)的自适应放射治疗(ART)工作流程,该流程通过自动图像跟踪来识别需要适应的主要解剖结构变化。在这项研究中,我们报告了该程序的初步临床经验,并研究了潜在的 ART 触发信号。
在 C 臂 LINAC 上对接受头颈部放射治疗的患者进行离线 ART。适应性治疗在治疗期间的单个时间点进行,大约在治疗 3 周时进行重新模拟。在整个治疗过程中,所有患者均使用称为自适应放射治疗环境自动监视(AWARE)的自动图像跟踪系统进行跟踪。AWARE 通过锥形束 CT 扫描和变形配准来测量大体肿瘤体积(GTV)和选定的正常组织的体积变化。通过比较自适应计划的剂量学和重新模拟 CT 扫描计算的初始计划的正常组织并发症概率来确定 ART 的益处。然后将剂量学差异与 AWARE 测量的体积变化相关联,以确定针对 ART 的患者特异性触发因素。使用接收者操作特征分析评估候选触发变量。
共有 46 名患者在这项研究中接受了 ART。在这些患者中,我们观察到下颌下腺(平均±标准差:-219.2±291.2 cGy,P<10),腮腺(-68.2±197.7 cGy,P=0.001)和口腔(-238.7±206.7 cGy,P<10)的剂量明显降低。根据平均腮腺剂量计算的口干症的正常组织并发症概率也随着自适应计划的进行而显著降低(P=0.008)。我们还观察到 GTV 和正常组织的治疗期间系统体积减小(ΔV)。确定了一些候选触发因素,这些触发因素表明 ART 具有显著改善,包括腮腺 ΔV=7%,颈部 ΔV=2%和淋巴结 GTV ΔV=29%。
在常规 LINAC 上成功部署了系统性的头颈部离线 ART,降低了对关键唾液结构和口腔的剂量。自动锥形束 CT 跟踪提供了有关解剖结构变化的信息,这可能有助于针对 ART 的患者特异性触发。